This discrepancy for 786-O cells may be related to the high levels of a long non-coding EGFR antisense mRNA (EGFR-AS1) already described as a marker of poor prognosis in RCC 30 and which modulates ERLO efficacy in head and neck carcinoma 31. Here, EGFR is linked to head and neck carcinoma.